首页 > 最新文献

Therapeutic advances in reproductive health最新文献

英文 中文
Comparing visual estimation and hematocrit change in the assessment of blood loss among women undergoing cesarean delivery in a tertiary facility in northern Uganda. 乌干达北部一家三级医院在评估剖宫产产妇失血量时,比较目测和血细胞比容变化。
IF 3.1 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-17 eCollection Date: 2024-01-01 DOI: 10.1177/26334941241289552
Robert Edilu, Aaron Sanvu, James Ecuut, Alban Odong, Felix Bongomin, Ritah Nantale, Jackline Ayikoru, Baifa Arwinyo, Sande Ojara, Pebalo Francis Pebolo

Background: Cesarean section poses a fourfold risk for postpartum hemorrhage (PPH), necessitating accurate blood loss estimation to enable timely interventions. However, the conventional visual estimation method often leads to underestimation, resulting in undiagnosed PPH even in our setting, Uganda. Yet, the quantitative standard techniques remain underutilized.

Objective: We compared visual and calculated blood loss among women undergoing cesarean delivery at Gulu Regional Referral Hospital in northern Uganda.

Design: We employed a cross-sectional study design.

Methods: We enrolled pregnant women scheduled for cesarean section and determined both calculated and visually estimated blood loss. Data analysis involved using Pearson's moment correlation coefficient to compare the two methods and logistic regression to determine the factors associated with PPH.

Results: We included 105 participants, most were primigravida (n = 100, 43%), aged 15-24 years (n = 100, 52%), with term gestation (n = 100, 75%). The mean visual estimated blood loss (vEBL) was 235.3 ± 123.7 ml (interquartile range (IQR) 50-600 ml), while the calculated estimated blood loss (cEBL) was 435.0 ± 1328.2 ml (IQR -11,182.1-2226.7 ml). Visual estimation underestimated blood loss in 90% of cases (n = 100), and 21% (n = 21) had undiagnosed PPH (>1000 ml blood loss). None of the respondents had PPH (>1000 ml blood loss) following vEBL. There was a small positive correlation between both methods (vEBL and cEBL; r = 0.1165; p = 0.2482). Women aged >35 years were 1.60 times more likely to experience PPH than their counterparts aged 25-34 years (adjusted odds ratio (AOR): 1.60; 95% CI: 1.11-2.30, p < 0.011). Chorioamnionitis increased the risk of PPH by 2.2 times (AOR: 2.20; 95% CI: 1.20-4.05, p < 0.012).

Conclusion: The visual estimation technique significantly underestimated blood loss in up to 90% of cases, particularly during emergency cesarean sections. Among the 21% of cases diagnosed with PPH based on calculated blood loss, advanced maternal age and chorioamnionitis were notable contributing factors. Routine hemoglobin and hematocrit testing in obstetric care can be effectively utilized to objectively assess blood loss, aiding in the accurate diagnosis and management of PPH. Implementing these measures, even in resource-constrained settings, can significantly reduce the morbidity and mortality associated with PPH.

Trial registration: Not applicable.

背景:剖腹产导致产后出血(PPH)的风险高达四倍,因此必须准确估计失血量,以便及时采取干预措施。然而,传统的目测估算法往往会导致低估,从而导致即使在乌干达也无法诊断出 PPH。然而,定量标准技术仍未得到充分利用:我们比较了乌干达北部古卢地区转诊医院剖宫产产妇的目测失血量和计算失血量:设计:我们采用了横断面研究设计:我们招募了计划进行剖腹产的孕妇,并确定了计算失血量和目测失血量。数据分析包括使用皮尔逊矩相关系数对两种方法进行比较,以及使用逻辑回归法确定与 PPH 相关的因素:我们纳入了 105 名参与者,其中大多数为初产妇(100 人,占 43%),年龄在 15-24 岁之间(100 人,占 52%),妊娠足月(100 人,占 75%)。平均目测失血量(vEBL)为 235.3 ± 123.7 毫升(四分位距(IQR)50-600 毫升),而计算失血量(cEBL)为 435.0 ± 1328.2 毫升(IQR -11,182.1-2226.7 毫升)。90%的病例(n = 100)的目测估计值低估了失血量,21%的病例(n = 21)未确诊为 PPH(失血量大于 1000 毫升)。没有一名受访者在进行 vEBL 后出现 PPH(失血量大于 1000 毫升)。两种方法(vEBL 和 cEBL;r = 0.1165;p = 0.2482)之间存在微小的正相关性。年龄大于 35 岁的女性发生 PPH 的几率是 25-34 岁女性的 1.60 倍(调整后的几率比 (AOR):1.60;95% CI:1.11-2.30,p p 结论:在多达 90% 的病例中,目测估计技术严重低估了失血量,尤其是在紧急剖宫产手术中。在根据计算失血量确诊为 PPH 的 21% 病例中,高龄产妇和绒毛膜羊膜炎是显著的诱因。产科护理中的常规血红蛋白和血细胞比容检测可有效用于客观评估失血量,帮助准确诊断和处理 PPH。即使在资源有限的情况下,实施这些措施也能显著降低与 PPH 相关的发病率和死亡率:试验注册:不适用。
{"title":"Comparing visual estimation and hematocrit change in the assessment of blood loss among women undergoing cesarean delivery in a tertiary facility in northern Uganda.","authors":"Robert Edilu, Aaron Sanvu, James Ecuut, Alban Odong, Felix Bongomin, Ritah Nantale, Jackline Ayikoru, Baifa Arwinyo, Sande Ojara, Pebalo Francis Pebolo","doi":"10.1177/26334941241289552","DOIUrl":"10.1177/26334941241289552","url":null,"abstract":"<p><strong>Background: </strong>Cesarean section poses a fourfold risk for postpartum hemorrhage (PPH), necessitating accurate blood loss estimation to enable timely interventions. However, the conventional visual estimation method often leads to underestimation, resulting in undiagnosed PPH even in our setting, Uganda. Yet, the quantitative standard techniques remain underutilized.</p><p><strong>Objective: </strong>We compared visual and calculated blood loss among women undergoing cesarean delivery at Gulu Regional Referral Hospital in northern Uganda.</p><p><strong>Design: </strong>We employed a cross-sectional study design.</p><p><strong>Methods: </strong>We enrolled pregnant women scheduled for cesarean section and determined both calculated and visually estimated blood loss. Data analysis involved using Pearson's moment correlation coefficient to compare the two methods and logistic regression to determine the factors associated with PPH.</p><p><strong>Results: </strong>We included 105 participants, most were primigravida (<i>n</i> = 100, 43%), aged 15-24 years (<i>n</i> = 100, 52%), with term gestation (<i>n</i> = 100, 75%). The mean visual estimated blood loss (vEBL) was 235.3 ± 123.7 ml (interquartile range (IQR) 50-600 ml), while the calculated estimated blood loss (cEBL) was 435.0 ± 1328.2 ml (IQR -11,182.1-2226.7 ml). Visual estimation underestimated blood loss in 90% of cases (<i>n</i> = 100), and 21% (<i>n</i> = 21) had undiagnosed PPH (>1000 ml blood loss). None of the respondents had PPH (>1000 ml blood loss) following vEBL. There was a small positive correlation between both methods (vEBL and cEBL; <i>r</i> = 0.1165; <i>p</i> = 0.2482). Women aged >35 years were 1.60 times more likely to experience PPH than their counterparts aged 25-34 years (adjusted odds ratio (AOR): 1.60; 95% CI: 1.11-2.30, <i>p</i> < 0.011). Chorioamnionitis increased the risk of PPH by 2.2 times (AOR: 2.20; 95% CI: 1.20-4.05, <i>p</i> < 0.012).</p><p><strong>Conclusion: </strong>The visual estimation technique significantly underestimated blood loss in up to 90% of cases, particularly during emergency cesarean sections. Among the 21% of cases diagnosed with PPH based on calculated blood loss, advanced maternal age and chorioamnionitis were notable contributing factors. Routine hemoglobin and hematocrit testing in obstetric care can be effectively utilized to objectively assess blood loss, aiding in the accurate diagnosis and management of PPH. Implementing these measures, even in resource-constrained settings, can significantly reduce the morbidity and mortality associated with PPH.</p><p><strong>Trial registration: </strong>Not applicable.</p>","PeriodicalId":75219,"journal":{"name":"Therapeutic advances in reproductive health","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11492183/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142482658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring challenges to the uptake of sexual and reproductive health services among lesbian and bisexual women in Bulawayo, Zimbabwe: a qualitative enquiry. 探索津巴布韦布拉瓦约女同性恋和双性恋妇女接受性健康和生殖健康服务所面临的挑战:定性调查。
IF 3.1 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-17 eCollection Date: 2024-01-01 DOI: 10.1177/26334941241289553
Methembe Yotamu Khozah, Wilfred Njabulo Nunu

Background: Reproductive healthcare is essential for all people, including lesbian and bisexual women. However, lesbians and bisexual women are among society's most marginalised and excluded members.

Objective: This study aimed to explore the challenges faced by lesbian and bisexual women in accessing Sexual and Reproductive Health (SRH) Services in Bulawayo, Zimbabwe.

Design: An exploratory, descriptive qualitative study was conducted on two populations that included eight participants identified through the Voice of the Voiceless organisation in Bulawayo and 10 key informants and probed the challenges faced by lesbians and bisexual women when accessing SRH services.

Methods: Data were gathered through 10 key informant interviews and 1 focus group discussion (FGD; with 8 participants). The interviews and FGDs were recorded, transcribed verbatim, coded and thematically analysed.

Results: The themes that emerged included the uptake of SRH services among lesbians and bisexual women, the challenges faced by lesbians and bisexual women when accessing SRH services, and strategies to aid the uptake of SRH services by lesbians and bisexual women. The findings showed that the uptake of SRH services was generally low and was influenced by factors such as clinical settings. The challenges mentioned included stigma and the unavailability of specific lesbian and bisexual women's services. By contrast, the most frequent strategies included affirmative training for healthcare providers and improved clinical settings to become friendly and inclusive.

Conclusion: There is an imperative for targeted SRH services that address the distinct needs of lesbians and bisexual women, in line with the 95-95-95 strategy and Sustainable Development Goals target 3.7. The observed low uptake of these services can be attributed to several systemic barriers, including inadequate training of health providers, negative attitudes and lack of inclusive policies. Enhancing the sensitivity of health facilities, strengthening links to sexual health education and implementing supportive legal frameworks are essential steps to improve SRH outcomes in this population. These findings elucidate critical gaps within the current healthcare system and present significant opportunities for policymakers to formulate evidence-based strategies to ensure equitable access to SRH services, thereby advancing public health objectives.

背景:生殖保健对所有人都至关重要,包括女同性恋者和双性恋妇女。然而,女同性恋者和双性恋妇女是社会中最边缘化和最受排斥的成员:本研究旨在探讨津巴布韦布拉瓦约的女同性恋者和双性恋妇女在获得性与生殖健康(SRH)服务时所面临的挑战:对两个人群进行了探索性、描述性定性研究,其中包括通过布拉瓦约 "无声者之声 "组织确认的 8 名参与者和 10 名关键信息提供者,并探讨了女同性恋者和双性恋妇女在获得性与生殖健康服务时面临的挑战:通过 10 次关键信息提供者访谈和 1 次焦点小组讨论(FGD,8 人参加)收集数据。对访谈和 FGD 进行了录音、逐字记录、编码和主题分析:出现的主题包括女同性恋者和双性恋妇女对性健康和生殖健康服务的接受情况、女同性恋者和双性恋妇女在获得性健康和生殖健康服务时面临的挑战以及帮助女同性恋者和双性恋妇女接受性健康和生殖健康服务的策略。研究结果表明,性健康和生殖健康服务的接受率普遍较低,并受到临床环境等因素的影响。提到的挑战包括污名化以及没有专门针对女同性恋和双性恋妇女的服务。与此相反,最常见的策略包括对医疗服务提供者进行平权培训,以及改善临床环境,使其变得友好和具有包容性:根据 "95-95-95 "战略和可持续发展目标的具体目标 3.7,有必要提供有针对性的性健康和生殖健康服务,以满足女同性恋者和双性恋妇女的独特需求。所观察到的对这些服务的低接受率可归因于几个系统性障碍,包括对医疗服务提供者的培训不足、消极态度和缺乏包容性政策。提高医疗机构的敏感性、加强与性健康教育的联系以及实施支持性法律框架,是改善这一人群性健康和生殖健康成果的必要步骤。这些研究结果阐明了当前医疗保健系统中存在的关键差距,并为政策制定者提供了制定循证战略的重要机会,以确保公平获得性健康和生殖健康服务,从而推进公共卫生目标的实现。
{"title":"Exploring challenges to the uptake of sexual and reproductive health services among lesbian and bisexual women in Bulawayo, Zimbabwe: a qualitative enquiry.","authors":"Methembe Yotamu Khozah, Wilfred Njabulo Nunu","doi":"10.1177/26334941241289553","DOIUrl":"10.1177/26334941241289553","url":null,"abstract":"<p><strong>Background: </strong>Reproductive healthcare is essential for all people, including lesbian and bisexual women. However, lesbians and bisexual women are among society's most marginalised and excluded members.</p><p><strong>Objective: </strong>This study aimed to explore the challenges faced by lesbian and bisexual women in accessing Sexual and Reproductive Health (SRH) Services in Bulawayo, Zimbabwe.</p><p><strong>Design: </strong>An exploratory, descriptive qualitative study was conducted on two populations that included eight participants identified through the Voice of the Voiceless organisation in Bulawayo and 10 key informants and probed the challenges faced by lesbians and bisexual women when accessing SRH services.</p><p><strong>Methods: </strong>Data were gathered through 10 key informant interviews and 1 focus group discussion (FGD; with 8 participants). The interviews and FGDs were recorded, transcribed verbatim, coded and thematically analysed.</p><p><strong>Results: </strong>The themes that emerged included the uptake of SRH services among lesbians and bisexual women, the challenges faced by lesbians and bisexual women when accessing SRH services, and strategies to aid the uptake of SRH services by lesbians and bisexual women. The findings showed that the uptake of SRH services was generally low and was influenced by factors such as clinical settings. The challenges mentioned included stigma and the unavailability of specific lesbian and bisexual women's services. By contrast, the most frequent strategies included affirmative training for healthcare providers and improved clinical settings to become friendly and inclusive.</p><p><strong>Conclusion: </strong>There is an imperative for targeted SRH services that address the distinct needs of lesbians and bisexual women, in line with the 95-95-95 strategy and Sustainable Development Goals target 3.7. The observed low uptake of these services can be attributed to several systemic barriers, including inadequate training of health providers, negative attitudes and lack of inclusive policies. Enhancing the sensitivity of health facilities, strengthening links to sexual health education and implementing supportive legal frameworks are essential steps to improve SRH outcomes in this population. These findings elucidate critical gaps within the current healthcare system and present significant opportunities for policymakers to formulate evidence-based strategies to ensure equitable access to SRH services, thereby advancing public health objectives.</p>","PeriodicalId":75219,"journal":{"name":"Therapeutic advances in reproductive health","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11492191/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142482669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of artificial intelligence in transforming maternity services in Africa: prospects and challenges. 人工智能在非洲孕产服务转型中的作用:前景与挑战。
IF 3.1 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-15 eCollection Date: 2024-01-01 DOI: 10.1177/26334941241288587
Obasanjo Afolabi Bolarinwa, Aliu Mohammed, Victor Igharo
{"title":"The role of artificial intelligence in transforming maternity services in Africa: prospects and challenges.","authors":"Obasanjo Afolabi Bolarinwa, Aliu Mohammed, Victor Igharo","doi":"10.1177/26334941241288587","DOIUrl":"10.1177/26334941241288587","url":null,"abstract":"","PeriodicalId":75219,"journal":{"name":"Therapeutic advances in reproductive health","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11503737/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of urine protein-creatinine ratio and urine dipstick test for significant proteinuria in preeclamptic women. 比较尿蛋白-肌酐比值和尿液量筒检测法,以确定是否有明显蛋白尿的先兆子痫妇女。
IF 3.1 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-10-09 eCollection Date: 2024-01-01 DOI: 10.1177/26334941241288841
Chinedu L Olisa, Betrand O Nwosu, George U Eleje, Charlotte B Oguejiofor, Innocent I Mbachu, Chukwudi A Ogabido, Tobechi K Njoku, Chidinma C Okafor, Zebulon C Okechukwu, Chukwunwendu F Okeke, Ifeanyi O Okonkwo, Emmanuel I Okaforcha, Chukwunonso I Enechukwu, Chito P Ilika, Obinna K Nnabuchi, Ugochukwu H Osuafor, Harrison C Ugwuoroko, Emmanuel C Egwuatu, Martin C Andeh, Chigozie G Okafor
<p><strong>Background: </strong>Assessing for significant proteinuria in pregnancy (SPIP) stands as a key indicator for diagnosing preeclampsia. However, the initial method typically employed for this assessment, the urine dipstick test, often yields inaccurate results. While a 24-h urine collection is considered the most reliable test, its implementation can lead to delays in diagnosis, potentially affecting both maternal and fetal well-being. The urine protein-creatinine (P/Cr) ratio can be used as an alternative to 24-h urine protein analysis, but its diagnostic accuracy has remained uncertain. There is a need to compare the diagnostic accuracy of urine P/Cr ratio and dipstick urinalysis for SPIP, especially in resource-poor settings.</p><p><strong>Objectives: </strong>To determine and compare the diagnostic accuracy of urine P/Cr ratio and dipstick urinalysis in a spot urine specimen for the diagnosis of SPIP among women evaluated for preeclampsia using 24-h urine protein excretions as a gold standard.</p><p><strong>Design: </strong>This is a comparative cross-sectional study.</p><p><strong>Methods: </strong>The study involved 82 singleton pregnant women evaluated for preeclampsia from 20 weeks of gestation who underwent dipstick and P/Cr ratio tests in the same urine sample. Women at risk of preeclampsia were given a specimen container for the collection of urine samples on an outpatient basis. Participants were trained and told to collect the urine sample 24 h prior to their next antenatal appointment. However, those on admission and evaluated for preeclampsia had their 24-h urine collected in the hospital. The outcome measures included sensitivity, specificity, positive predictive value, negative predictive value, likelihood ratio and accuracy for the two tests. Significant proteinuria was defined as a P/Cr ratio >0.27 or ⩾2+ of proteinuria on the dipstick test. Preeclampsia was confirmed in women with both high blood pressure and SPIP.</p><p><strong>Results: </strong>The mean age of participants was 28.65 ± 5.76 years. Comparatively, the diagnostic accuracy (91.46% (95% CI = 83.29-96.59) vs 59.76% (95% CI = 48.34-70.44), <i>p</i> = 0.001), sensitivity (94.74% vs 70.00%, <i>p</i> = 0.021), specificity (84.00% vs 43.75%, <i>p</i> = 0.001), negative predictive value (87.50% vs 48.28%, <i>p</i> = 0.003) and positive predictive value (93.10% vs 66.04%, <i>p</i> = 0.001), respectively, were higher for the spot urine P/Cr ratio than dipstick test. In addition, the positive likelihood ratio and the negative likelihood ratio for spot urine P/Cr ratio versus dipstick test were (1.93 vs 1.24) and (0.07 vs 0.69), respectively.</p><p><strong>Conclusion: </strong>The spot urine P/Cr has superior diagnostic accuracy in the determination of significant proteinuria in pregnant women being evaluated for preeclampsia than the widely used dipstick test. A more robust multicenter study is needed to compare the diagnostic accuracy of spot urine PCR with the st
背景:评估妊娠期大量蛋白尿(SPIP)是诊断子痫前期的一个关键指标。然而,这种评估通常采用的初始方法--尿液浸量棒测试--往往会产生不准确的结果。虽然收集 24 小时的尿液被认为是最可靠的检测方法,但采用这种方法会导致诊断延误,从而可能影响孕妇和胎儿的健康。尿蛋白-肌酐(P/Cr)比值可作为 24 小时尿蛋白分析的替代方法,但其诊断准确性仍不确定。有必要比较尿蛋白/肌酐比值和浸量式尿液分析对 SPIP 的诊断准确性,尤其是在资源匮乏的环境中:以 24 小时尿蛋白排泄量为金标准,确定并比较尿液 P/Cr 比值和点滴尿液标本中沾取的尿液进行 SPIP 诊断的准确性:这是一项横断面比较研究:这项研究涉及 82 名从妊娠 20 周开始接受子痫前期评估的单胎孕妇,她们在同一尿样中接受了浸量尺和 P/Cr 比值检测。有先兆子痫风险的妇女在门诊时会得到一个用于收集尿样的标本容器。参与者接受了培训,并被告知应在下次产前预约前 24 小时采集尿样。然而,那些入院并被评估为子痫前期的患者则在医院收集其 24 小时尿液。结果测量包括两种检测方法的灵敏度、特异性、阳性预测值、阴性预测值、似然比和准确性。明显蛋白尿的定义是 P/Cr 比值大于 0.27,或用浸量棒检测时蛋白尿量⩾2+。同时患有高血压和 SPIP 的妇女被确诊为子痫前期:参与者的平均年龄为 28.65±5.76 岁。相比之下,诊断准确率(91.46% (95% CI = 83.29-96.59) vs 59.76% (95% CI = 48.34-70.44), p = 0.001)、灵敏度(94.74% vs 70.00%, p = 0.021)、特异性(84.00% vs 43.75%, p = 0.001)、阴性预测值(87.50% vs 48.28%,p = 0.003)和阳性预测值(93.10% vs 66.04%,p = 0.001)分别高于点滴试验。此外,定点尿液 P/Cr 比值的阳性似然比和阴性似然比分别为(1.93 vs 1.24)和(0.07 vs 0.69):与广泛使用的量表测试相比,定点尿 P/Cr 在确定评估子痫前期的孕妇是否有明显蛋白尿方面具有更高的诊断准确性。在低收入环境中,需要进行更有力的多中心研究,以比较定点尿液 PCR 与标准 24 小时尿蛋白的诊断准确性。
{"title":"Comparison of urine protein-creatinine ratio and urine dipstick test for significant proteinuria in preeclamptic women.","authors":"Chinedu L Olisa, Betrand O Nwosu, George U Eleje, Charlotte B Oguejiofor, Innocent I Mbachu, Chukwudi A Ogabido, Tobechi K Njoku, Chidinma C Okafor, Zebulon C Okechukwu, Chukwunwendu F Okeke, Ifeanyi O Okonkwo, Emmanuel I Okaforcha, Chukwunonso I Enechukwu, Chito P Ilika, Obinna K Nnabuchi, Ugochukwu H Osuafor, Harrison C Ugwuoroko, Emmanuel C Egwuatu, Martin C Andeh, Chigozie G Okafor","doi":"10.1177/26334941241288841","DOIUrl":"https://doi.org/10.1177/26334941241288841","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Assessing for significant proteinuria in pregnancy (SPIP) stands as a key indicator for diagnosing preeclampsia. However, the initial method typically employed for this assessment, the urine dipstick test, often yields inaccurate results. While a 24-h urine collection is considered the most reliable test, its implementation can lead to delays in diagnosis, potentially affecting both maternal and fetal well-being. The urine protein-creatinine (P/Cr) ratio can be used as an alternative to 24-h urine protein analysis, but its diagnostic accuracy has remained uncertain. There is a need to compare the diagnostic accuracy of urine P/Cr ratio and dipstick urinalysis for SPIP, especially in resource-poor settings.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objectives: &lt;/strong&gt;To determine and compare the diagnostic accuracy of urine P/Cr ratio and dipstick urinalysis in a spot urine specimen for the diagnosis of SPIP among women evaluated for preeclampsia using 24-h urine protein excretions as a gold standard.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Design: &lt;/strong&gt;This is a comparative cross-sectional study.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;The study involved 82 singleton pregnant women evaluated for preeclampsia from 20 weeks of gestation who underwent dipstick and P/Cr ratio tests in the same urine sample. Women at risk of preeclampsia were given a specimen container for the collection of urine samples on an outpatient basis. Participants were trained and told to collect the urine sample 24 h prior to their next antenatal appointment. However, those on admission and evaluated for preeclampsia had their 24-h urine collected in the hospital. The outcome measures included sensitivity, specificity, positive predictive value, negative predictive value, likelihood ratio and accuracy for the two tests. Significant proteinuria was defined as a P/Cr ratio &gt;0.27 or ⩾2+ of proteinuria on the dipstick test. Preeclampsia was confirmed in women with both high blood pressure and SPIP.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;The mean age of participants was 28.65 ± 5.76 years. Comparatively, the diagnostic accuracy (91.46% (95% CI = 83.29-96.59) vs 59.76% (95% CI = 48.34-70.44), &lt;i&gt;p&lt;/i&gt; = 0.001), sensitivity (94.74% vs 70.00%, &lt;i&gt;p&lt;/i&gt; = 0.021), specificity (84.00% vs 43.75%, &lt;i&gt;p&lt;/i&gt; = 0.001), negative predictive value (87.50% vs 48.28%, &lt;i&gt;p&lt;/i&gt; = 0.003) and positive predictive value (93.10% vs 66.04%, &lt;i&gt;p&lt;/i&gt; = 0.001), respectively, were higher for the spot urine P/Cr ratio than dipstick test. In addition, the positive likelihood ratio and the negative likelihood ratio for spot urine P/Cr ratio versus dipstick test were (1.93 vs 1.24) and (0.07 vs 0.69), respectively.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;The spot urine P/Cr has superior diagnostic accuracy in the determination of significant proteinuria in pregnant women being evaluated for preeclampsia than the widely used dipstick test. A more robust multicenter study is needed to compare the diagnostic accuracy of spot urine PCR with the st","PeriodicalId":75219,"journal":{"name":"Therapeutic advances in reproductive health","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11467826/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142482668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive endometriosis care: a modern multimodal approach for the treatment of pelvic pain and endometriosis. 子宫内膜异位症综合护理:治疗盆腔疼痛和子宫内膜异位症的现代多模式方法。
IF 3.1 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-23 eCollection Date: 2024-01-01 DOI: 10.1177/26334941241277759
Ido Mick, Shay M Freger, Jolanda van Keizerswaard, Mahsa Gholiof, Mathew Leonardi

Endometriosis is a prevalent gynecological disease, leading to chronic pain and inflammation, affecting 1 in 10 individuals presumed female at birth. The diagnostic journey is often arduous, marked by neglect of the right diagnosis and prolonged wait times, significantly compromising the quality of life among those affected. This review provides a nuanced exploration of endometriosis-associated pain management, encompassing medical, surgical, and holistic approaches, all guided by accurate and refined diagnostics. Our paramount goal is to empower physicians as key figures in confronting this intricate challenge with a patient-centric approach, ultimately aiming to improve treatment and quality of life. Acknowledging each patient's unique needs, we emphasize the importance of tailoring a spectrum of options informed by current literature and insights gleaned from our experience in a high-volume tertiary endometriosis center. It is imperative to recognize endometriosis as a complex and chronic disease, often occurring with co-morbid conditions and nuanced complexities, necessitating a long-term personalized multimodal approach for each case. In addition, incorporating principles such as patient autonomy, profound respect for diverse experiences, and practical education on treatment choices is pivotal in enhancing treatment outcomes and overall patient satisfaction.

子宫内膜异位症是一种常见的妇科疾病,可导致慢性疼痛和炎症,每 10 个出生时被假定为女性的人中就有 1 人患病。子宫内膜异位症的诊断过程往往十分艰辛,其特点是忽视正确诊断和等待时间过长,严重影响了患者的生活质量。本综述对子宫内膜异位症相关疼痛的治疗进行了细致入微的探讨,包括内科、外科和整体治疗方法,所有这些都以准确、精细的诊断为指导。我们的首要目标是赋予医生权力,使他们成为以患者为中心应对这一复杂挑战的关键人物,最终达到改善治疗和生活质量的目的。考虑到每位患者的独特需求,我们强调根据当前的文献资料和我们在子宫内膜异位症三级诊疗中心积累的经验,量身定制一系列治疗方案的重要性。我们必须认识到,子宫内膜异位症是一种复杂的慢性疾病,往往伴有并发症和微妙的复杂性,因此必须针对每个病例采取长期的个性化多模式治疗方法。此外,将患者自主权、对不同经历的深刻尊重以及关于治疗选择的实用教育等原则纳入其中,对于提高治疗效果和患者总体满意度至关重要。
{"title":"Comprehensive endometriosis care: a modern multimodal approach for the treatment of pelvic pain and endometriosis.","authors":"Ido Mick, Shay M Freger, Jolanda van Keizerswaard, Mahsa Gholiof, Mathew Leonardi","doi":"10.1177/26334941241277759","DOIUrl":"https://doi.org/10.1177/26334941241277759","url":null,"abstract":"<p><p>Endometriosis is a prevalent gynecological disease, leading to chronic pain and inflammation, affecting 1 in 10 individuals presumed female at birth. The diagnostic journey is often arduous, marked by neglect of the right diagnosis and prolonged wait times, significantly compromising the quality of life among those affected. This review provides a nuanced exploration of endometriosis-associated pain management, encompassing medical, surgical, and holistic approaches, all guided by accurate and refined diagnostics. Our paramount goal is to empower physicians as key figures in confronting this intricate challenge with a patient-centric approach, ultimately aiming to improve treatment and quality of life. Acknowledging each patient's unique needs, we emphasize the importance of tailoring a spectrum of options informed by current literature and insights gleaned from our experience in a high-volume tertiary endometriosis center. It is imperative to recognize endometriosis as a complex and chronic disease, often occurring with co-morbid conditions and nuanced complexities, necessitating a long-term personalized multimodal approach for each case. In addition, incorporating principles such as patient autonomy, profound respect for diverse experiences, and practical education on treatment choices is pivotal in enhancing treatment outcomes and overall patient satisfaction.</p>","PeriodicalId":75219,"journal":{"name":"Therapeutic advances in reproductive health","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11457249/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reproductive and oncologic outcomes in young women with uterine sarcoma undergoing fertility-sparing treatment: a systematic review. 接受保留生育力治疗的年轻子宫肉瘤患者的生殖和肿瘤治疗效果:系统性综述。
IF 3.1 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-09-23 eCollection Date: 2024-01-01 DOI: 10.1177/26334941241271563
Andrea Etrusco, Vittorio Agrifoglio, Antonio Simone Laganà, Elko Gliozheni, Annamaria Caringella, Antonio Stanziano, Ettore Cicinelli, Vito Chiantera, Andrea Giannini, Baydaa Alsannan, Fabio Barra, Antonio D'Amato

Background: Uterine sarcomas (US) are rare cancer of possible occurrence even in women of childbearing age. To date, total hysterectomy is the standard treatment in the early stages. The possibilities of carrying out fertility-sparing treatments (FST) to save the fertility of women with unfulfilled reproductive desires are described in the literature, but to date, they can only be considered experimental.

Objective: The aim of this systematic review was to evaluate the oncological and reproductive outcomes of women with different histological types of US undergoing FST.

Design: Systematic review.

Data sources and methods: Electronic databases were searched for English-language studies describing FST for US until January 31, 2024.

Results: Forty-five papers which met the abovementioned inclusion criteria, were included in the qualitative analysis. Quantitative analysis was not possible because of the heterogeneity of the data. A descriptive summary of the results according to the histotype of US was provided. Six hundred forty-one patients of childbearing age with US and undergoing FST. After treatment with FST, 89 (13.9%) disease recurrences and 107 (16.7%) pregnancies were recorded.

Conclusion: In selected cases of early-stage US, FST may be proposed. However, the patient must be informed of the real possibility of recurrence and potentially difficult achievement of pregnancy. Additional well-designed prospective studies and clinical trials are needed to address the knowledge gaps and enhance clinical decision-making in this population.

Trial registration: PROSPERO ID: CRD42024509356.

背景:子宫肉瘤(US)是一种罕见的癌症,即使在育龄妇女中也有可能发生。迄今为止,全子宫切除术是早期阶段的标准治疗方法。文献中描述了通过保留生育力治疗(FST)来挽救生育愿望未得到满足的妇女的生育力的可能性,但迄今为止,这些治疗只能被认为是实验性的:本系统性综述旨在评估不同组织学类型的 US 妇女接受 FST 治疗后的肿瘤和生育结果:数据来源和方法在电子数据库中搜索了截至2024年1月31日的描述US的FST的英文研究:符合上述纳入标准的 45 篇论文被纳入定性分析。由于数据的异质性,无法进行定量分析。根据美国的组织类型对结果进行了描述性总结。641 名育龄期 US 患者接受了 FST 治疗。经 FST 治疗后,89 例(13.9%)疾病复发,107 例(16.7%)妊娠:结论:在选定的早期 US 病例中,可建议使用 FST。然而,必须告知患者复发的实际可能性以及怀孕的潜在困难。需要进行更多设计良好的前瞻性研究和临床试验,以填补知识空白并加强该人群的临床决策:PROSPERO ID:CRD42024509356。
{"title":"Reproductive and oncologic outcomes in young women with uterine sarcoma undergoing fertility-sparing treatment: a systematic review.","authors":"Andrea Etrusco, Vittorio Agrifoglio, Antonio Simone Laganà, Elko Gliozheni, Annamaria Caringella, Antonio Stanziano, Ettore Cicinelli, Vito Chiantera, Andrea Giannini, Baydaa Alsannan, Fabio Barra, Antonio D'Amato","doi":"10.1177/26334941241271563","DOIUrl":"10.1177/26334941241271563","url":null,"abstract":"<p><strong>Background: </strong>Uterine sarcomas (US) are rare cancer of possible occurrence even in women of childbearing age. To date, total hysterectomy is the standard treatment in the early stages. The possibilities of carrying out fertility-sparing treatments (FST) to save the fertility of women with unfulfilled reproductive desires are described in the literature, but to date, they can only be considered experimental.</p><p><strong>Objective: </strong>The aim of this systematic review was to evaluate the oncological and reproductive outcomes of women with different histological types of US undergoing FST.</p><p><strong>Design: </strong>Systematic review.</p><p><strong>Data sources and methods: </strong>Electronic databases were searched for English-language studies describing FST for US until January 31, 2024.</p><p><strong>Results: </strong>Forty-five papers which met the abovementioned inclusion criteria, were included in the qualitative analysis. Quantitative analysis was not possible because of the heterogeneity of the data. A descriptive summary of the results according to the histotype of US was provided. Six hundred forty-one patients of childbearing age with US and undergoing FST. After treatment with FST, 89 (13.9%) disease recurrences and 107 (16.7%) pregnancies were recorded.</p><p><strong>Conclusion: </strong>In selected cases of early-stage US, FST may be proposed. However, the patient must be informed of the real possibility of recurrence and potentially difficult achievement of pregnancy. Additional well-designed prospective studies and clinical trials are needed to address the knowledge gaps and enhance clinical decision-making in this population.</p><p><strong>Trial registration: </strong>PROSPERO ID: CRD42024509356.</p>","PeriodicalId":75219,"journal":{"name":"Therapeutic advances in reproductive health","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11440568/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142334029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of vitamin A with gestational diabetes and thyroid disorders in pregnancy and their influence on maternal, fetal, and neonatal outcomes. 维生素 A 与妊娠期糖尿病和妊娠期甲状腺疾病的关系及其对母体、胎儿和新生儿结局的影响。
IF 3.1 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-31 eCollection Date: 2024-01-01 DOI: 10.1177/26334941241271542
Abdul Qadeer, Muhammad Umer Ishaq, Adnan Safi, Anum Akbar, Sana Asif, Aqsa Komel, Digbijay Kunwar, Syed Mujtaba Azhar Bokhari

Gestational diabetes mellitus (GDM) and thyroid disorders during pregnancy pose significant health concerns, impacting a substantial number of mothers globally. Globally, about 14% of pregnant women develop GDM, while thyroid disorders impact approximately 2%-3%. Both conditions contribute to adverse outcomes, including gestational hypertension, excessive fetal growth, and heightened perinatal morbidity. The central focus of this literature review is to examine the relationship between vitamin A, a crucial fat-soluble micronutrient in fetal development, and the occurrence of GDM and thyroid disorders during pregnancy. The primary research question investigates the association between vitamin A, GDM, and thyroid disorders, analyzing their combined impact on maternal, fetal, and neonatal outcomes. The review underscores the potential of vitamin A to modulate the risk and outcomes of GDM and thyroid disorders during gestation, emphasizing its role in GDM development and resolution and its influence on thyroid function in pregnancy.

妊娠期糖尿病(GDM)和妊娠期甲状腺疾病是重大的健康问题,影响着全球大量的母亲。全球约有 14% 的孕妇罹患妊娠期糖尿病,约有 2%-3% 的孕妇受到甲状腺疾病的影响。这两种疾病都会导致不良后果,包括妊娠高血压、胎儿生长过快和围产期发病率增高。本文献综述的重点是研究维生素 A(一种对胎儿发育至关重要的脂溶性微量营养素)与妊娠期 GDM 和甲状腺疾病之间的关系。主要研究问题是调查维生素 A、GDM 和甲状腺疾病之间的关系,分析它们对孕产妇、胎儿和新生儿结局的综合影响。综述强调了维生素 A 调节妊娠期 GDM 和甲状腺疾病的风险和结局的潜力,强调了维生素 A 在 GDM 的发展和缓解中的作用及其对妊娠期甲状腺功能的影响。
{"title":"Association of vitamin A with gestational diabetes and thyroid disorders in pregnancy and their influence on maternal, fetal, and neonatal outcomes.","authors":"Abdul Qadeer, Muhammad Umer Ishaq, Adnan Safi, Anum Akbar, Sana Asif, Aqsa Komel, Digbijay Kunwar, Syed Mujtaba Azhar Bokhari","doi":"10.1177/26334941241271542","DOIUrl":"10.1177/26334941241271542","url":null,"abstract":"<p><p>Gestational diabetes mellitus (GDM) and thyroid disorders during pregnancy pose significant health concerns, impacting a substantial number of mothers globally. Globally, about 14% of pregnant women develop GDM, while thyroid disorders impact approximately 2%-3%. Both conditions contribute to adverse outcomes, including gestational hypertension, excessive fetal growth, and heightened perinatal morbidity. The central focus of this literature review is to examine the relationship between vitamin A, a crucial fat-soluble micronutrient in fetal development, and the occurrence of GDM and thyroid disorders during pregnancy. The primary research question investigates the association between vitamin A, GDM, and thyroid disorders, analyzing their combined impact on maternal, fetal, and neonatal outcomes. The review underscores the potential of vitamin A to modulate the risk and outcomes of GDM and thyroid disorders during gestation, emphasizing its role in GDM development and resolution and its influence on thyroid function in pregnancy.</p>","PeriodicalId":75219,"journal":{"name":"Therapeutic advances in reproductive health","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11366108/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142115827","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Validation of the follicular and ovarian thresholds by an 18-MHz ultrasound imaging in polycystic ovary syndrome: a pilot cutoff for North African patients. 多囊卵巢综合征的 18-MHz 超声波成像卵泡和卵巢阈值的验证:北非患者的试验性临界值。
IF 3.1 Q1 OBSTETRICS & GYNECOLOGY Pub Date : 2024-08-20 eCollection Date: 2024-01-01 DOI: 10.1177/26334941241270372
Taieb Ach, Ayoub Guesmi, Maha Kalboussi, Fatma Ben Abdessalem, Emna Mraihi, Houda El Mhabrech

Background: Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrinopathies among young women. Ultrasound evidence of polycystic ovaries is one of its crucial diagnostic criteria.

Objectives: Our main objective is to study the contribution of ultrasound data in diagnosing PCOS. In addition, we aim to establish a new cutoff point for the use of ultrasound and to determine its sensitivity as well as its specificity.

Design: It was a prospective study, including all patients presenting with clinical hyperandrogenism.

Methods: The ultrasound examination of these patients was performed using a novel ultrasound machine (18 MHz) compared to an older ultrasound machine (2 Hz-8 MHz). Inclusion criteria encompassed adult female patients over 18 years presenting symptoms suggestive of PCOS, particularly hyperandrogenism and oligo-anovulation, meeting Rotterdam's diagnostic criteria. Prior to inclusion, assessments were conducted to eliminate other potential causes explaining hyperandrogenism or menstrual disorders in both groups.

Results: We examined 92 patients diagnosed with PCOS. Menstrual disorders were the main symptoms, with amenorrhea being more frequent in the PCOS group (G1) (48.9% vs the control group (G2): 11.1%). The follicle number was significantly lower in the control group, as assessed by both ultrasound machines (p < 10-3). The accuracy of the new ultrasound device was evaluated compared to the old one using the receiver operating characteristic (ROC) curve, revealing a cutoff of 18 follicles (sensitivity of 68.1%, specificity of 100%) and an area under the curve of 0.955. We found a significant difference between the median values of the number of follicles (NF) by both ultrasound machines (18 vs 12). It was positively correlated with an index of r = 0.916. For the volume, it was distinctively higher in G1 (p < 10-3). ROC curve analysis revealed an ovarian volume cutoff of 9.25 ml with a sensitivity of 48.9% and a specificity of 100%. Both ultrasound machines were positively correlated with an index of r = 0.979 (p < 10-3).

Conclusion: In conclusion, we were able to establish significant correlations between the new and the old ultrasound devices for both the NF and ovarian volume. Our study is distinctive as it represents the first on the African continent to re-evaluate the ultrasound criterion for PCOS.

背景:多囊卵巢综合征(PCOS多囊卵巢综合征(PCOS)是年轻女性中最常见的内分泌疾病之一。多囊卵巢的超声波证据是其重要的诊断标准之一:我们的主要目的是研究超声波数据对诊断多囊卵巢综合症的贡献。此外,我们还旨在为超声波的使用确定一个新的临界点,并确定其敏感性和特异性:这是一项前瞻性研究,包括所有出现临床高雄激素症的患者:对这些患者进行超声波检查时,使用的是新型超声波机(18 MHz)与老式超声波机(2 Hz-8 MHz)。纳入标准包括18岁以上、出现多囊卵巢综合征症状,尤其是高雄激素和少排卵,符合鹿特丹诊断标准的成年女性患者。在纳入之前,我们对两组患者进行了评估,以排除引起高雄激素症或月经紊乱的其他潜在原因:我们对 92 名确诊为多囊卵巢综合症的患者进行了检查。月经紊乱是主要症状,多囊卵巢综合征组(G1)的闭经发生率更高(48.9%,对照组(G2)为 11.1%):11.1%).对照组的卵泡数量明显低于多囊卵巢综合症组,两种超声波仪器的评估结果都是如此(P-3)。使用接收器操作特征曲线(ROC)评估了新超声设备与旧设备的准确性,结果显示,18 个卵泡为临界值(灵敏度为 68.1%,特异性为 100%),曲线下面积为 0.955。我们发现,两种超声设备的卵泡数(NF)中位值(18 对 12)之间存在明显差异。两者呈正相关,指数为 r = 0.916。至于卵泡体积,G1 的数值明显更高(p -3)。ROC 曲线分析显示,卵巢体积的临界值为 9.25 毫升,敏感性为 48.9%,特异性为 100%。两种超声设备呈正相关,指数为 r = 0.979(p -3):总之,我们能够确定新旧超声设备在 NF 和卵巢体积方面的显著相关性。我们的研究与众不同,因为它是非洲大陆首个重新评估多囊卵巢综合症超声标准的研究。
{"title":"Validation of the follicular and ovarian thresholds by an 18-MHz ultrasound imaging in polycystic ovary syndrome: a pilot cutoff for North African patients.","authors":"Taieb Ach, Ayoub Guesmi, Maha Kalboussi, Fatma Ben Abdessalem, Emna Mraihi, Houda El Mhabrech","doi":"10.1177/26334941241270372","DOIUrl":"10.1177/26334941241270372","url":null,"abstract":"<p><strong>Background: </strong>Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrinopathies among young women. Ultrasound evidence of polycystic ovaries is one of its crucial diagnostic criteria.</p><p><strong>Objectives: </strong>Our main objective is to study the contribution of ultrasound data in diagnosing PCOS. In addition, we aim to establish a new cutoff point for the use of ultrasound and to determine its sensitivity as well as its specificity.</p><p><strong>Design: </strong>It was a prospective study, including all patients presenting with clinical hyperandrogenism.</p><p><strong>Methods: </strong>The ultrasound examination of these patients was performed using a novel ultrasound machine (18 MHz) compared to an older ultrasound machine (2 Hz-8 MHz). Inclusion criteria encompassed adult female patients over 18 years presenting symptoms suggestive of PCOS, particularly hyperandrogenism and oligo-anovulation, meeting Rotterdam's diagnostic criteria. Prior to inclusion, assessments were conducted to eliminate other potential causes explaining hyperandrogenism or menstrual disorders in both groups.</p><p><strong>Results: </strong>We examined 92 patients diagnosed with PCOS. Menstrual disorders were the main symptoms, with amenorrhea being more frequent in the PCOS group (G1) (48.9% vs the control group (G2): 11.1%). The follicle number was significantly lower in the control group, as assessed by both ultrasound machines (<i>p</i> < 10<sup>-3</sup>). The accuracy of the new ultrasound device was evaluated compared to the old one using the receiver operating characteristic (ROC) curve, revealing a cutoff of 18 follicles (sensitivity of 68.1%, specificity of 100%) and an area under the curve of 0.955. We found a significant difference between the median values of the number of follicles (NF) by both ultrasound machines (18 vs 12). It was positively correlated with an index of r = 0.916. For the volume, it was distinctively higher in G1 (<i>p</i> < 10<sup>-3</sup>). ROC curve analysis revealed an ovarian volume cutoff of 9.25 ml with a sensitivity of 48.9% and a specificity of 100%. Both ultrasound machines were positively correlated with an index of r = 0.979 (<i>p</i> < 10<sup>-3</sup>).</p><p><strong>Conclusion: </strong>In conclusion, we were able to establish significant correlations between the new and the old ultrasound devices for both the NF and ovarian volume. Our study is distinctive as it represents the first on the African continent to re-evaluate the ultrasound criterion for PCOS.</p>","PeriodicalId":75219,"journal":{"name":"Therapeutic advances in reproductive health","volume":null,"pages":null},"PeriodicalIF":3.1,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11337176/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142019862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Women's willingness for cervical cancer screening and associated factors among women attending health services in Addis Ababa, Ethiopia. 埃塞俄比亚亚的斯亚贝巴妇女接受宫颈癌筛查的意愿及相关因素。
Pub Date : 2024-06-07 eCollection Date: 2024-01-01 DOI: 10.1177/26334941241253181
Tangute Demas, Teshale Biku, Tewodros Getinet, Bereket Fantahun, Delayehu Bekele, Negat Woldehawariat, Rahel Muzemir, Martha Shoarega

Background: Cervical cancer is one of the most common causes of cancer-related morbidity and mortality globally. In developed countries, effective screening programs reduced its burden. However, in Ethiopia, cervical cancer remains a major public health problem despite the screening service being available free of charge.

Objective: The aim of this study was to assess women's willingness for cervical cancer screening services and associated factors among women attending health services in Addis Ababa, Ethiopia.

Design: An institutional-based, analytic, cross-sectional study was conducted among sexually active women attending health facilities from August to September 2022.

Methods: A pretested interviewer-administered questionnaire was used for data collection. Data were analyzed using SPSS version 25. Logistic regression was used to determine different variables' frequencies and associated factors. A p value of <0.05 was considered statistically significant.

Result: Four hundred twenty-two women were approached, and 394 (93.4%) met the study inclusion criteria. Study participants had a minimum of 1 and a maximum of 6 sexual partners in their lives. A total of 256 (64.9%) study participants had heard about cervical cancer. Among those who heard about cervical cancer, only 22 (8.6%) had been tested for cervical cancer. Of those who did not receive cervical cancer screening, only 175 (47.0%) are willing to receive cervical cancer screening. Age, religion, marital status, place of residence, educational level, occupation, and hearing about cervical cancer were found to be statistically significant. Women who heard about cervical cancer were 15.2 times more likely to take the test compared to those who never heard about cervical cancer before the study.

Conclusion: Women's willingness to be screened for cervical cancer is low despite many of the study participants having more than one partner in their lives and being at risk for cervical cancer. Only a few participants had been screened for cervical cancer. Women who had heard about cervical cancer were more likely to take the screening service compared to those who had never heard it before. This highlights the need to prioritize raising awareness about the benefits of cervical cancer screening services.

背景:宫颈癌是导致全球癌症相关发病率和死亡率的最常见原因之一。在发达国家,有效的筛查计划减轻了宫颈癌的负担。然而,在埃塞俄比亚,尽管筛查服务是免费提供的,但宫颈癌仍然是一个重大的公共卫生问题:本研究旨在评估埃塞俄比亚亚的斯亚贝巴接受医疗服务的妇女对宫颈癌筛查服务的意愿及相关因素:设计:在 2022 年 8 月至 9 月期间,对到医疗机构就诊的性活跃妇女进行了一项以机构为基础的横断面分析研究:方法:采用预先测试的访谈者管理问卷进行数据收集。数据使用 SPSS 25 版进行分析。采用逻辑回归法确定不同变量的频率和相关因素。结果共接触了 422 名妇女,其中 394 人(93.4%)符合研究的纳入标准。研究参与者一生中的性伴侣最少为 1 个,最多为 6 个。共有 256 名(64.9%)研究参与者听说过宫颈癌。在听说过宫颈癌的人中,只有 22 人(8.6%)接受过宫颈癌检测。在没有接受过宫颈癌筛查的人中,只有 175 人(47.0%)愿意接受宫颈癌筛查。研究发现,年龄、宗教信仰、婚姻状况、居住地、教育程度、职业和是否听说过宫颈癌等因素在统计学上都有重要意义。与研究前从未听说过宫颈癌的妇女相比,听说过宫颈癌的妇女接受检查的可能性要高 15.2 倍:结论:尽管许多参与研究的女性在生活中有不止一个伴侣,并且有患宫颈癌的风险,但她们接受宫颈癌筛查的意愿并不高。只有少数参与者接受过宫颈癌筛查。与从未听说过宫颈癌的妇女相比,听说过宫颈癌的妇女更愿意接受筛查服务。这突出表明,有必要优先提高人们对宫颈癌筛查服务益处的认识。
{"title":"Women's willingness for cervical cancer screening and associated factors among women attending health services in Addis Ababa, Ethiopia.","authors":"Tangute Demas, Teshale Biku, Tewodros Getinet, Bereket Fantahun, Delayehu Bekele, Negat Woldehawariat, Rahel Muzemir, Martha Shoarega","doi":"10.1177/26334941241253181","DOIUrl":"10.1177/26334941241253181","url":null,"abstract":"<p><strong>Background: </strong>Cervical cancer is one of the most common causes of cancer-related morbidity and mortality globally. In developed countries, effective screening programs reduced its burden. However, in Ethiopia, cervical cancer remains a major public health problem despite the screening service being available free of charge.</p><p><strong>Objective: </strong>The aim of this study was to assess women's willingness for cervical cancer screening services and associated factors among women attending health services in Addis Ababa, Ethiopia.</p><p><strong>Design: </strong>An institutional-based, analytic, cross-sectional study was conducted among sexually active women attending health facilities from August to September 2022.</p><p><strong>Methods: </strong>A pretested interviewer-administered questionnaire was used for data collection. Data were analyzed using SPSS version 25. Logistic regression was used to determine different variables' frequencies and associated factors. A <i>p</i> value of <0.05 was considered statistically significant.</p><p><strong>Result: </strong>Four hundred twenty-two women were approached, and 394 (93.4%) met the study inclusion criteria. Study participants had a minimum of 1 and a maximum of 6 sexual partners in their lives. A total of 256 (64.9%) study participants had heard about cervical cancer. Among those who heard about cervical cancer, only 22 (8.6%) had been tested for cervical cancer. Of those who did not receive cervical cancer screening, only 175 (47.0%) are willing to receive cervical cancer screening. Age, religion, marital status, place of residence, educational level, occupation, and hearing about cervical cancer were found to be statistically significant. Women who heard about cervical cancer were 15.2 times more likely to take the test compared to those who never heard about cervical cancer before the study.</p><p><strong>Conclusion: </strong>Women's willingness to be screened for cervical cancer is low despite many of the study participants having more than one partner in their lives and being at risk for cervical cancer. Only a few participants had been screened for cervical cancer. Women who had heard about cervical cancer were more likely to take the screening service compared to those who had never heard it before. This highlights the need to prioritize raising awareness about the benefits of cervical cancer screening services.</p>","PeriodicalId":75219,"journal":{"name":"Therapeutic advances in reproductive health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11162127/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141297541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of the Gulu University Reproductive Health Simulation Training for final year medical students and interns: a before-and-after study. 古卢大学对毕业班医学生和实习生进行生殖健康模拟培训的效果:前后对比研究。
Pub Date : 2024-05-24 eCollection Date: 2024-01-01 DOI: 10.1177/26334941241251967
Pebalo Francis Pebolo, Jerom Okot, Felix Bongomin, Silvia Awor, Baifa Arwinyo, Sande Ojara, Jimmyy Opee, Ayikoru Jackline, Eric Ssennuni, Simple Ouma

Background: Reproductive health emergencies, such as postpartum hemorrhage, contribute significantly to maternal and neonatal morbidity and mortality in Uganda due to knowledge and skills gaps. Medical interns, intern midwives, and nurses are crucial as frontline healthcare workers in responding to these emergencies. Our proposed hands-on strategy involves comprehensive simulation-based training (SBT) to equip these healthcare workers with the essential knowledge to manage common reproductive health emergencies and procedures in the country.

Objectives: The study aimed to assess the effectiveness of comprehensive SBT in improving the knowledge of interns and fifth-year medical students on reproductive health emergencies and procedures at Gulu University and its Teaching Hospitals in Uganda.

Design: A before-and-after study.

Methods: A 4-day SBT was conducted for fifth-year medical students and interns (nurses, midwives, and doctors) at Gulu University Teaching Hospitals, focusing on reproductive health emergencies. Pre- and post-tests with 40 multiple-choice questions were used to evaluate knowledge enhancement, the scores were summarized as medians and interquartile ranges. Paired sample t-tests was used to test the difference in pre- and post-test scores. Independent sample t-tests compared median post-test results between interns and students, with a p-value <0.05 considered significant.

Results: A total of 153 participants were enrolled, the majority being males (78.4%, n = 120) and medical students (73.9%, n = 113). Among the 40 interns, 55% (n = 22) were doctors, 30% (n = 12) were midwives, and 15% (n = 6) were nurses. The study participants showed an increase in knowledge, with median post-test scores higher than pre-test scores for all participants [63% (interquartile ranges, IQR: 57-71%) versus 49% (42-54%), with a median difference of 14% (8-23%), p < 0.001].

Conclusion: The SBT effectively imparts key knowledge competencies to the interns and fifth-year medical students. We recommend that SBT be included as part of the course units that students should take and for continuous medical education for qualified healthcare workers in resource-limited settings.

背景:在乌干达,由于知识和技能方面的差距,产后出血等生殖健康突发事件大大增加了孕产妇和新生儿的发病率和死亡率。医学实习生、实习助产士和护士作为一线医护人员,在应对这些紧急情况时至关重要。我们建议的实践策略包括全面的模拟培训(SBT),使这些医护人员掌握处理该国常见生殖健康紧急情况和程序的基本知识:该研究旨在评估综合模拟培训在提高乌干达古卢大学及其教学医院实习生和五年级医学生生殖健康急诊和手术知识方面的效果:设计:前后对比研究:在古卢大学教学医院为五年级医学生和实习生(护士、助产士和医生)开展了为期 4 天的 SBT,重点是生殖健康紧急情况。前测和后测中的 40 道选择题用于评估知识的增长情况,得分汇总为中位数和四分位数之间的范围。采用配对样本 t 检验来检验测试前后得分的差异。独立样本 t 检验比较了实习生和学生的后测成绩中位数,P 值为 结果:共有 153 人参加,其中大部分为男性(78.4%,n = 120)和医科学生(73.9%,n = 113)。在 40 名实习生中,55%(n = 22)是医生,30%(n = 12)是助产士,15%(n = 6)是护士。研究参与者的知识水平有所提高,所有参与者的测试后得分中位数均高于测试前得分[63%(四分位数间距,IQR:57-71%)对 49%(42-54%),中位数差异为 14% (8-23%),P 结论:SBT 有效地传授了关键知识:SBT 能有效地向实习生和五年级医学生传授关键知识能力。我们建议将 SBT 作为学生应修课程单元的一部分,并纳入资源有限环境中合格医护人员的继续医学教育中。
{"title":"Efficacy of the Gulu University Reproductive Health Simulation Training for final year medical students and interns: a before-and-after study.","authors":"Pebalo Francis Pebolo, Jerom Okot, Felix Bongomin, Silvia Awor, Baifa Arwinyo, Sande Ojara, Jimmyy Opee, Ayikoru Jackline, Eric Ssennuni, Simple Ouma","doi":"10.1177/26334941241251967","DOIUrl":"10.1177/26334941241251967","url":null,"abstract":"<p><strong>Background: </strong>Reproductive health emergencies, such as postpartum hemorrhage, contribute significantly to maternal and neonatal morbidity and mortality in Uganda due to knowledge and skills gaps. Medical interns, intern midwives, and nurses are crucial as frontline healthcare workers in responding to these emergencies. Our proposed hands-on strategy involves comprehensive simulation-based training (SBT) to equip these healthcare workers with the essential knowledge to manage common reproductive health emergencies and procedures in the country.</p><p><strong>Objectives: </strong>The study aimed to assess the effectiveness of comprehensive SBT in improving the knowledge of interns and fifth-year medical students on reproductive health emergencies and procedures at Gulu University and its Teaching Hospitals in Uganda.</p><p><strong>Design: </strong>A before-and-after study.</p><p><strong>Methods: </strong>A 4-day SBT was conducted for fifth-year medical students and interns (nurses, midwives, and doctors) at Gulu University Teaching Hospitals, focusing on reproductive health emergencies. Pre- and post-tests with 40 multiple-choice questions were used to evaluate knowledge enhancement, the scores were summarized as medians and interquartile ranges. Paired sample <i>t</i>-tests was used to test the difference in pre- and post-test scores. Independent sample <i>t</i>-tests compared median post-test results between interns and students, with a <i>p</i>-value <0.05 considered significant.</p><p><strong>Results: </strong>A total of 153 participants were enrolled, the majority being males (78.4%, <i>n</i> = 120) and medical students (73.9%, <i>n</i> = 113). Among the 40 interns, 55% (<i>n</i> = 22) were doctors, 30% (<i>n</i> = 12) were midwives, and 15% (<i>n</i> = 6) were nurses. The study participants showed an increase in knowledge, with median post-test scores higher than pre-test scores for all participants [63% (interquartile ranges, IQR: 57-71%) <i>versus</i> 49% (42-54%), with a median difference of 14% (8-23%), <i>p</i> < 0.001].</p><p><strong>Conclusion: </strong>The SBT effectively imparts key knowledge competencies to the interns and fifth-year medical students. We recommend that SBT be included as part of the course units that students should take and for continuous medical education for qualified healthcare workers in resource-limited settings.</p>","PeriodicalId":75219,"journal":{"name":"Therapeutic advances in reproductive health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11127575/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141155904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Therapeutic advances in reproductive health
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1